NEW YORK, March 20, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the BioAmber Inc. ("BioAmber" or the "Company") (BIOA). Such investors are advised to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/bioa.
The investigation concerns whether BioAmber and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On March 16, 2017 after-market hours, BioAmber revealed disappointing financial results for its 2016 fiscal year, missing its previously issued revenue forecast by $1.3 million. On the conference call, company's President Fabrice Orecchioni, attributed the unfortunate results to "pricing pressures" and "a disruption from a large customer that was expected to purchase 2.8 million of succinic acid in Q4 2016, but due to a technical problem in its manufacturing facility postponed the order to 2017." Following this news, BioAmber stock dropped during intraday trading on March 17, 2017.
If you are aware of any facts relating to this investigation, or purchased BioAmber shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/bioa. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-bioamber-inc-bioa-300425843.html